Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly targeting EGFR (epidermal growth factor receptor) for potential cancer therapies. Its structure allows selective binding and modulation of enzyme activity involved in tumor growth. Commonly employed in structure-activity relationship (SAR) studies to develop more potent and selective anticancer agents. Also utilized in radiolabeling studies to track drug distribution and metabolism in preclinical models.